CTLA4 and cancer: Indeed, appropriate stimuli such as IDO1 inhibitors, anti-CTLA-4 and/or PD-1, electrochemotherapy and MDA5 stimulation seem to restore LC functions, paving the way for future immunotherapeutic strategies and future cancer vaccines capable of pharmacologically reactivating DCs/LCs and restore antitumor immunity (Figure 3).